APC and breast cancer: It is well-established that APC is abnormally methylated in both breast cancer (81, 82) and ovarian cancer (83, 84), therefore it cannot be ruled out that APC might affect cancer cell responsiveness to anti-tumor drugs through gene silencing induced by promoter methylation.